Sanofi to Acquire Provention Bio for $2.9 Billion
- March 17, 2023
Sanofi will buy U.S.-based Provention Bio, Inc. for $2.9 billion in a deal that will add to the French pharmaceutical manufacturer's existing diabetes drug portfolio.
ARTICLE TAGS
You must be logged in to access this content.